Connect with us

National

Drawbacks of the TGA’s cannabis changes for listed pot stocks – Small Caps

Having been subject to a harsh reality check over the last year or so, the ASX-listed cannabis sector is applauding the local medicine regulator’s endorsement of the weed as an effective therapy that should be more freely available to the ailing masses.

Published

on

post featured image

Having been subject to a harsh reality check over the last year or so, the ASX-listed cannabis sector is applauding the local medicine regulators endorsement of the weed as an effective therapy that should be more freely available to the ailing masses.
But the path to the pharmacy is likely to be harder than they think, with an emerging supply glut pushing prices to record lows.
In an interim ruling this month, the Therapeutic Goods Administration (TGA) said it intended to downgrade low-dose c…

Click here to view the original article.

Safety Mate